Winston J. Churchill, Director at Baudax Bio, Inc. (BXRX), bought 25,000 shares at $0.78 ($20K) on 2021-06-07, disclosed to the SEC on 2021-06-08.
Open-market purchase of $20k BXRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.78 | 10,000 | $8K | 40.0% |
| 2 | $0.78 | 15,000 | $12K | 60.0% |
| Total | $0.78 avg | 25,000 | $20K | 100% |
| Filing → |
| AMKR | SELL | 2025-12-17 | $221K | — | Filing → |
| AMKR | SELL | 2024-08-29 | $659K | — | Filing → |
| AMKR | SELL | 2024-03-08 | $862K | — | Filing → |